Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NX
NX logo

NX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Quanex Building Products Corp (NX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.350
1 Day change
-1.98%
52 Week Range
22.980
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Quanex Building Products Corp (NX) is not a strong buy for a beginner, long-term investor at this moment. The stock is currently oversold, as indicated by the RSI, but lacks strong positive catalysts or proprietary trading signals to support an immediate purchase. The company's financial performance has been mixed, with recent improvements in gross margin and liquidity but a significant drop in net income and EPS year-over-year. Analysts have lowered price targets, and the uncertain outlook for FY26 suggests caution. While the options data indicates some bullish sentiment, it is not sufficient to outweigh the current challenges.

Technical Analysis

The stock is oversold with an RSI of 16.418, indicating potential for a rebound. However, the MACD is negatively expanding (-0.503), suggesting bearish momentum. The stock is trading near the support level of 18.883, with resistance at 20.669. Moving averages are converging, signaling indecision in price trends.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The Open Interest Put-Call Ratio of 1.26 indicates more open interest in puts than calls, suggesting cautious sentiment. However, the Option Volume Put-Call Ratio of 0.7 reflects higher call volume, indicating some bullish sentiment in the short term.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Improved gross margin and strong liquidity of $331.6 million. Dividend declaration of $0.08 per share with a forward yield of 1.53%.

Neutral/Negative Catalysts

  • Analysts have lowered price targets and expressed an uncertain outlook for FY

  • Bearish MACD and lack of proprietary trading signals.

Financial Performance

In Q1 2026, Quanex reported a 2.3% YoY increase in revenue to $409.1 million and improved gross margin. However, the company posted a net loss of $4.07 million and a non-GAAP EPS of -$0.01. In 2025/Q4, revenue dropped by 0.47% YoY, net income fell by 240.63% YoY, and EPS declined by 243.33% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Benchmark lowered the price target from $30 to $28 while maintaining a Buy rating. Analysts expect a flattish FY26, with challenges in the first half and a more favorable second half. EPS estimates for FY26 and FY27 have been revised lower due to an uncertain outlook.

Wall Street analysts forecast NX stock price to rise
1 Analyst Rating
Wall Street analysts forecast NX stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 17.700
sliders
Low
28
Averages
28
High
28
Current: 17.700
sliders
Low
28
Averages
28
High
28
Benchmark
analyst
Buy
maintain
$30 -> $28
AI Analysis
2025-12-15
Reason
Benchmark
analyst
Price Target
$30 -> $28
AI Analysis
2025-12-15
maintain
Buy
Reason
Benchmark lowered the firm's price target on Quanex to $28 from $30 and keeps a Buy rating on the shares. While FY26 guidance has been pushed to the company's Q1 results release, management's current view is for a flattish year-over-year comparison with the first half likely more challenged than the back half, notes the analyst, who is moving the firm's FY26 and FY27 EPS estimates lower given the uncertain outlook.

People Also Watch